Sotera Health Co Ordinary Shares SHC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $18.15
- Day Range
- $18.14–18.49
- 52-Week Range
- $10.95–19.85
- Bid/Ask
- $18.21 / $18.22
- Shares Outstanding
- 285.17M
- Market Cap
- $5.18B
- Volume/Avg
- 1M / 3M
Key Statistics
- Price/Earnings (Normalized)
- 20.18
- Price/Sales
- 4.39
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 3,000
- Website
- https://www.soterahealth.com
Valuation
|
Metric
|
SHC
|
|---|---|
Price/Earnings (Normalized) | 20.18 |
Price/Book Value | 8.31 |
Price/Sales | 4.39 |
Price/Cash Flow | 21.41 |
Price/Earnings
SHC
Financial Strength
|
Metric
|
SHC
|
|---|---|
Quick Ratio | 2.36 |
Current Ratio | 2.82 |
Interest Coverage | 2.37 |
Quick Ratio
SHC
Profitability
|
Metric
|
SHC
|
|---|---|
Return on Assets (Normalized) | 8.09% |
Return on Equity (Normalized) | 47.84% |
Return on Invested Capital (Normalized) | 13.25% |
Return on Assets
SHC
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|xjyDRG&$ | LOCK|FR | $199B | |||
| Danaher Corp
DHR
| LOCK|@%H!!R?J | LOCK|!!^ | $142B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|?pF>X^@X | LOCK|pz% | $44B | |||
| Agilent Technologies Inc
A
| LOCK|TbftJm& | LOCK|FJ? | $38B | |||
| Waters Corp
WAT
| LOCK|s&zJVFl | LOCK|Q^! | $37B | |||
| IQVIA Holdings Inc
IQV
| LOCK|tw!B<g | LOCK|W!yKH | $35B | |||
| Illumina Inc
ILMN
| LOCK|s<#<$^R | LOCK|&$^^J | $28B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|??!wgqW | LOCK|Wf$s | $27B | |||
| Quest Diagnostics Inc
DGX
| LOCK|xtl$GH | LOCK|wB>c< | $22B | |||
| Labcorp Holdings Inc
LH
| LOCK|D?tCF$^ | LOCK|DNCPC | $22B |
United States